0.05Open0.05Pre Close0 Volume18 Open Interest2.50Strike Price0.00Turnover5493.76%IV53.61%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1774Delta0.4245Gamma33.20Leverage Ratio-4.8061Theta0.0000Rho5.89Eff Leverage0.0000Vega
TherapeuticsMD Stock Discussion
The company also released its Q3 financial report, posting a net loss from continuing operations of $0.13 per share...
• $AmerisourceBergen (ABC.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $178 (from $167)
• $Arch Resources (ARCH.US)$ : Jefferies Upgrades to Buy From Hold - PT $225 (from $160)
• $BHP Group Ltd (BHP.US)$ : Jefferies Upgrades to Buy From Hold - PT $82 (from $72)
• $Peabody Energy (BTU.US)$ : Jefferies Upgrades to Buy From Hold - PT $36 (from $25)
• $Warrior Met Coal (HCC.US)$ : Jefferies Upgrades to Buy From Hold - PT $50 (from $36)
• $Liberty Global-A (LBTYA.US)$ : Berenbe...
• $Boot Barn Holdings (BOOT.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $121 (from $109)
• $EPAM Systems (EPAM.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $400 (from $312)
• $Hersha Hospitality Trust (HT.US)$ : Stifel Upgrades to Buy from Hold - PT $14.50 (from $11)
• $Jounce Therapeutics (JNCE.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $20 (from $15)
• $Pactiv Evergreen (PTVE.US)$ : RBC Capital Upgra...
No comment yet